These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 6292254

  • 1. Calcium potentiates the cyclic nucleotide and phosphaturic response to parathyroid hormone infusion.
    Bikle DD, Herman RH.
    J Clin Endocrinol Metab; 1983 Jan; 56(1):11-7. PubMed ID: 6292254
    [Abstract] [Full Text] [Related]

  • 2. Rapid development of renal resistance to low doses of synthetic bovine parathyroid hormone fragment 1-34. Dissociation of urinary cyclic adenosine monophosphate, phosphaturic, and calciuric responses.
    Law WM, Heath H.
    J Clin Invest; 1983 Sep; 72(3):1106-13. PubMed ID: 6309905
    [Abstract] [Full Text] [Related]

  • 3. Parathyroid hormone does not increase nephrogenous cyclic AMP excretion by the dog.
    Fox J, Heath H.
    Endocrinology; 1980 Dec; 107(6):2124-5. PubMed ID: 6253291
    [Abstract] [Full Text] [Related]

  • 4. Synthetic human parathyroid hormone-(1-34) for the study of pseudohypoparathyroidism.
    Mallette LE, Kirkland JL, Gagel RF, Law WM, Heath H.
    J Clin Endocrinol Metab; 1988 Nov; 67(5):964-72. PubMed ID: 2846629
    [Abstract] [Full Text] [Related]

  • 5. Assessment of adenosine 3',5'-monophosphate excretion and an oral calcium tolerance test in the diagnosis of mild primary hyperparathyroidism.
    Madvig P, Young G, Marcus R.
    J Clin Endocrinol Metab; 1984 Mar; 58(3):480-7. PubMed ID: 6319454
    [Abstract] [Full Text] [Related]

  • 6. [The diagnostic value of the determination of cyclic 3',5'-adenosine monophosphate (cAMP) in urine].
    Gennari C, Galli M, Montagnani M, D'Amore I.
    Quad Sclavo Diagn; 1976 Mar; 12(1):15-38. PubMed ID: 190633
    [Abstract] [Full Text] [Related]

  • 7. Mechanism of resistance to the phosphaturic effect of the parathyroid hormone in the hamster.
    Knox FG, Preiss J, Kim JK, Dousa TP.
    J Clin Invest; 1977 Apr; 59(4):675-83. PubMed ID: 14974
    [Abstract] [Full Text] [Related]

  • 8. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers.
    Horwitz MJ, Tedesco MB, Sereika SM, Hollis BW, Garcia-Ocaña A, Stewart AF.
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1603-9. PubMed ID: 12679445
    [Abstract] [Full Text] [Related]

  • 9. Renal-resistant hormonoplethoric hypoparathyroidism with evidence for a defective response to cAMP.
    Duck SC, Rosenberg EM, Ratzan SK, Haymond MW.
    J Clin Endocrinol Metab; 1978 Sep; 47(3):640-6. PubMed ID: 233678
    [Abstract] [Full Text] [Related]

  • 10. Renal adenylate cyclase and the interrelationship between parathyroid hormone and vitamin D in the regulation of urinary phosphate and adenosine cyclic 3',5'-monophosphate excretion.
    Forte LR, Nickols GA, Anast CS.
    J Clin Invest; 1976 Mar; 57(3):559-68. PubMed ID: 175088
    [Abstract] [Full Text] [Related]

  • 11. Nephrogenous cyclic AMP levels in primary hyperparathyroidism.
    Babka JC, Bower RH, Sode J.
    Arch Intern Med; 1976 Oct; 136(10):1140-4. PubMed ID: 184749
    [Abstract] [Full Text] [Related]

  • 12. Effects of the intravenous administration of calcium on nephrogenous cyclic AMP: use as a parathyroid suppression test.
    Broadus AE, Deftos LJ, Bartter FC.
    J Clin Endocrinol Metab; 1978 Mar; 46(3):477-87. PubMed ID: 221521
    [Abstract] [Full Text] [Related]

  • 13. Urinary cyclic adenosine 3',5'-monophosphate response in McCune-Albright syndrome: clinical evidence for altered renal adenylate cyclase activity.
    Zung A, Chalew SA, Schwindinger WF, Levine MA, Phillip M, Jara A, Counts DR, Kowarski AA.
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3576-81. PubMed ID: 8530601
    [Abstract] [Full Text] [Related]

  • 14. Adenosine 3',5'-monophosphate response to parathyroid hormone: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism.
    Marx SJ, Spiegel AM, Sharp ME, Brown EM, Gardner DG, Downs RW, Attie MF, Stock JL.
    J Clin Endocrinol Metab; 1980 Mar; 50(3):546-8. PubMed ID: 6244324
    [Abstract] [Full Text] [Related]

  • 15. Effect of intravenous glucagon on the urinary excretion of adenosine 3',5'-monophosphate in man and in rats. Evidence for activation of renal adenylate cyclase and formation of nephrogenous cAMP.
    Rubinger D, Wald H, Friedlaender MM, Silver J, Popovtzer MM.
    Miner Electrolyte Metab; 1988 Mar; 14(4):211-20. PubMed ID: 2850459
    [Abstract] [Full Text] [Related]

  • 16. Renal effects of native parathyroid hormone and synthetic biologically active fragments in pseudohypoparathyroidism and hypoparathyroidism.
    Neer RM, Tregear GW, Potts JT.
    J Clin Endocrinol Metab; 1977 Feb; 44(2):420-3. PubMed ID: 190258
    [Abstract] [Full Text] [Related]

  • 17. A 6-hour human parathyroid hormone (1-34) infusion protocol: studies in normal and hypoparathyroid subjects.
    McElduff A, Lissner D, Wilkinson M, Cornish C, Posen S.
    Calcif Tissue Int; 1987 Nov; 41(5):267-73. PubMed ID: 2825934
    [Abstract] [Full Text] [Related]

  • 18. Abnormal responsiveness of nephrogenous cyclic AMP excretion following intravenously administered calcium in normocalcaemic squamous cell cancer patients.
    Naafs MA, Hackeng WH, Koorevaar G, Silberbusch J.
    Bone Miner; 1988 Jul; 4(3):289-98. PubMed ID: 2847840
    [Abstract] [Full Text] [Related]

  • 19. Effect of chlorpropamide on renal response to parathyroid hormone in normal subjects and in patients with hypoparathyroidism and pseudohypoparathyroidism.
    Coulson R, Moses AM.
    J Pharmacol Exp Ther; 1975 Sep; 194(3):603-13. PubMed ID: 169346
    [Abstract] [Full Text] [Related]

  • 20. Pseudohypoparathyroidism showing positive phosphaturic and negative cyclic AMP excretion response to parathyroid hormone.
    Higashi K, Honda K, Morita M, Umeda T, Shimada T, Kimura K, Shido T, Arita I, Sato T.
    Endocrinol Jpn; 1989 Aug; 36(4):465-9. PubMed ID: 2555146
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.